Dupilumab in atopic dermatitis, a protocol for SARS-COV-2-infected patients.

Ordóñez-Rubiano, Maria Fernanda; Campo, Isabela; Casas, Mirian

Ordóñez-Rubiano, Maria Fernanda; Campo, Isabela; Casas, Mirian.

Ordóñez-Rubiano MF; Atopic Dermatitis Clinic, Department of Dermatology, Cayre Clinical Center, Bogotá, Colombia.
Campo I; Division of Dermatology, Department of Internal Medicine, Military Central Hospital, Bogotá, Colombia.
Casas M; Division of Dermatology, Department of Internal Medicine, Military Central Hospital, Bogotá, Colombia.

Dermatol Ther ; 33(6): e14172, 2020 11.

Article in English | MEDLINE | ID: covidwho-780830

Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage; COVID-19/immunology; Dermatitis, Atopic/drug therapy; Dermatologic Agents/administration & dosage; SARS-CoV-2/immunology; Antibodies, Monoclonal, Humanized/adverse effects; COVID-19/diagnosis; COVID-19/virology; Dermatitis, Atopic/diagnosis; Dermatitis, Atopic/immunology; Dermatologic Agents/adverse effects; Drug Administration Schedule; Host-Pathogen Interactions; Humans; Immunocompromised Host; Male; Risk Assessment; Treatment Outcome; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Dermatitis, Atopic / Dermatologic Agents / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 Type of study: Case report / Diagnostic study / Prognostic study Limits: Adult / Humans / Male / Young adult Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2020 Document Type: Article Affiliation country: Dth.14172

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google